ストレプトゾトシン糖尿病ラットにおける二糖類水解酵素阻害剤AO‐128の改善作用

  • 小高 裕之
    武田薬品工業株式会社研究開発本部生物研究所
  • 松尾 隆夫
    武田薬品工業株式会社研究開発本部生物研究所

書誌事項

タイトル別名
  • Ameliorating Effects of an Intestinal Disaccharidase Inhibitor, AO-128, in Streptozotocin-diabetic Rats.
  • ストレプトゾトシン トウニョウビョウ ラット ニ オケル 2トウルイ スイカイ

この論文をさがす

抄録

The ameliorating activity of an intestinal disaccharidase inhibitor, AO-128, was evaluated in rats with diabetes of varying severity. Diabetic rats were produced by injecting 120mg/kg streptozotocin (STZ) into 1.5- and 5-day-old neonates. From the age of 9 week, the rats were given AO-128 as a dietary admixture at a dose of 5 mg/100g of diet for 28 days. AO-128 normalized the basal levels of plasma glucose, which were elevated, and both glucose tolerance and insulin response, which were impaired in animals injected with STZ at the age of 1.5 days. On the other hand, animals administered STZ at the age of 5 days showed overt diabetes syndrome including features such as hyperglycemia, hypoinsulinemia, hyperphagia, polydipsia, polyuria and glucosuria. AO-128 partly ameliorated these diabetic symptoms.

収録刊行物

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ